SEARCH RESULTS FOR:
Michael Zahra
FORMER PRESIDENT & CEO, DRONE DELIVERY CANADA
"Remote projects may prefer to isolate and limit the number of external individuals visiting as a precaution to avoid the virus spreading, but they need to maintain their supply chain so drones are a perfect unmanned logistics solution."
Martin Addy
TERRITORY MANAGER FOR EXPLOSIVES, ORICA GHANA
"Orica has also expanded beyond Ghana, and we have both underground and surface operations across West Africa."
Claudio Gorichon
CEO, GRUPO RENO S.A.
"Reno is always looking for new development alternatives and we favor organic growth."
LeRoy Danks & Brady Greifzu
MANAGER WEST REGION MINING & GLOBAL CORPORATE SALES EXECUTIVE, SOLENIS
"Solenis is a global specialty chemical manufacturer and one of three water treatment companies with a truly global footprint."
Louis Watum
PRESIDENT, CHAMBER OF MINES DRC
"I am concerned that the DRC is not fully capturing the opportunities of the commodity boom."
Hadley Natus
CHAIRMAN, TANTALEX LITHIUM RESOURCES
"I think Manono, for lithium, could become what Katanga has become for copper, and much more."
Eric Waldner
CEO, NEXANS KABELMETAL GHANA
"Ghana set an ambitious goal to be 100% electrified by 2024, which will be massively pushing our growth forward."
George Arhin
PARTNER AND PWC WEST AFRICA MINING LEADER
"This is the best time for mining companies to invest in cost optimization solutions to sustain their business when the gold prices dip."
Nery Echeverría
HEAD OF SALES – MEXICO, BAYER CROP SCIENCE
"Our global research on seeds creates applications based on each country’s needs. This contribute to sustainability by producing more tons per hectare, while other technologies provide more efficient water use."
Martín Toscano
PRESIDENT, EVONIK INDUSTRIES MEXICO
"Evonik can support industries in moving from a linear economy into a circular economy with the help of specialty chemicals."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
